Effect of pharmacogenomic testing for drug-gene interactions on medication selection and remission of symptoms in major depressive disorder

Oslin DW, Lynch KG, Shih M, Ingram EP, Wray LO, Chapman SR, Kranzler HR, Gelernter J, Pyne JM, Stone A, DuVall SL, Lehmann LS, Thase ME, and the PRIME Care Research Group
JAMA July 2022  

Latest News From Genomes2People